Estradiol-17β exerts profound neuroprotective actions following cerebral ischemia through multiple molecular mechanisms. To examine the putative anti-inflammatory mechanisms employed by estradiol during stroke, we explored the interactions between estradiol and inducible nitric oxide synthase (iNOS) in both wildtype and iNOS knockout (iNOSKO) female mice following permanent middle cerebral artery occlusion (MCAO). Female mice were ovariectomized and treated with estradiol. One week later, they were subjected to MCAO, and then killed 24 hours later. Analysis of total, cortical and striatal infarct volumes confirmed that estradiol is neuroprotective in wildtype mice. Infarct volumes were also significantly smaller in female iNOSKO female mice, but estradiol did not further decrease injury. We found that one mechanism by which estradiol may act is by decreasing nitric oxide synthase 2 gene expression in the cortex and in the striatum of wildtype mice. These results show that the pro-inflammatory actions of iNOS exacerbate stroke-induced injury within the cortex and striatum, and that iNOS deletion is neuroprotective in ovariectomized and estrogen-replaced female mice. Keywords estradiol; estrogen; iNOS; stroke; inflammation; nitric oxide synthase; ischemia; middle cerebral artery occlusion Stroke is a complex neurological disorder characterized by loss of cerebral blood flow, significant cell death, both necrotic and apoptotic in nature, and an enhanced inflammatory response (Dirnagl, et al., 1999). Women appear to be protected against stroke compared to men since studies show that premenopausal women have a lower incidence of stroke compared to age-matched males, but this protection is lost after the menopause (American Heart Association, 2004, Bushnell, et al., 2006. The biological basis of this protection has been thought to result from the neuroprotective properties of 17β-estradiol. However, the results of the Women's Health Initiative (WHI), which concluded that estrogen treatment afforded no Please address correspondence and reprint requests to: Candice M. Brown, Ph.D., Department of Physiology and Biophysics, University of Washington, 1959 NE Pacific St., Health Sciences Building BB-604, Box 356460, Seattle, WA 98195, Telephone: (206) Fax: (206) 543-5480, Email: canbrown@u.washington.edu. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. benefit or could increase risk for stroke in certain age groups, have encouraged reexamination of the actions of this hormone and its mechanisms of action (Anderson, et al., 2004, Rossouw, et al., 2007, Turgeon, et al., 2...